|
Originally published In Press as doi:10.1074/jbc.M201094200 on June 12, 2002
J. Biol. Chem., Vol. 277, Issue 34, 30477-30487, August 23, 2002
In Vivo and in Vitro Phosphorylation of
Two Isoforms of Yeast Pyruvate Kinase by Protein Kinase A*
Paula
Portela ,
Steven
Howell§,
Silvia
Moreno , and
Silvia
Rossi ¶
From the § Laboratory of Protein Structure,
National Institute for Medical Research, The Ridgeway, Mill Hill,
London NW7 1AA, United Kingdom and the Departamento de
Química Biológica, Facultad de Ciencias Exactas y
Naturales, Universidad de Buenos Aires, Ciudad Universitaria,
Pabellón 2, Buenos Aires 1428, Argentina
Received for publication, February 1, 2002, and in revised form, June 4, 2002
 |
ABSTRACT |
Saccharomyces cerevisiae
pyruvate kinase 1 (Pyk1) was demonstrated to be associated to an
immunoprecipitate of yeast protein kinase A holoenzyme
(HA-Tpk1·Bcy1) and to be phosphorylated in a
cAMP-dependent process. Both glutathione
S-transferase (GST)-Pyk1 and GST-Pyk2 were phosphorylated
in vitro by the bovine heart protein kinase A (PKA)
catalytic subunit and by immobilized yeast HA-Tpk1. The specificity
constant for the phosphorylation of GST-Pyk1 and GST-Pyk2 by bovine
catalytic subunit was in the range of the value for
Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide). Both fusion proteins were
phosphorylated in vivo, in intact cells overexpressing the
protein, or in vitro using crude extracts, as source of
protein kinase A, when a wild type strain was used but were not
phosphorylated when using a strain with only one TPK gene
with an attenuated mutation (tpk1w1). The effect of
phosphorylation on Pyk activity was assayed in partially purified
preparations from three strains, containing different endogenous
protein kinase A activity levels. Pyk1 activity was measured at
different phosphoenolpyruvate concentrations in the absence or in the
presence of the activator fructose 1,6-bisphosphate at 1.5 mM. Preliminary kinetic results derived from the comparison of Pyk1 obtained from extracts with the highest versus
those from the lowest protein kinase A activity indicate that the
enzyme is more active upon phosphorylation conditions; in the absence of the activator it shows a shift in the titration curve for
phosphoenolpyruvate to the left and an increase in the Hill
coefficient, whereas in the presence of fructose 1,6-bisphosphate it
shows an nH value of 1.4, as compared with an
nH of 2 for the Pyk1 obtained from extracts
with almost null protein kinase A activity.
 |
INTRODUCTION |
Protein phosphorylation is a universal regulatory mechanism; in
eukaryotic cells it is a phenomenon with implications in almost every
aspect of cell physiology and biochemistry. In Saccharomyces cerevisiae protein kinase A
(PKA)1 lies at the heart of
an important signal transduction pathway with key elements identified
principally in the 1980s. The PKA regulatory subunit is encoded by the
BCY1 gene, and the catalytic subunits are encoded by the
redundant TPK1, TPK2, and TPK3 genes (1, 2). In yeast, the PKA pathway controls many different targets at
the post-translational and transcriptional levels and has been
implicated in several different but interdependent cellular reactions
in response to changes in environmental conditions (3). Glucose is the
preferred carbon source of S. cerevisiae and as such is a
crucial regulator of cellular physiology. Transport and phosphorylation
of the sugar are required for most of its regulatory effects. PKA is
involved in one of the main regulatory systems transducing glucose
signals. Glucose triggers a rapid and transient increase in the levels
of the second messenger cAMP, synthesized by adenylate cyclase, which
is stimulated either by Ras proteins (possibly by reacting to
intracellular acidification) or by glucose via the Gpr1-Gpa2 G-protein
system (3, 4). Yeast cells, like other organisms or cells able to carry
out glycolysis and gluconeogenesis, have developed multiple regulatory
mechanisms to avoid the simultaneous operation of these antagonistic
metabolic pathways (5, 6). PKA has an input on this process by
regulation of some key enzymes either transcriptionally or
post-translationally. Although it may be clear that the activity of the
enzyme targets is regulated in response to PKA, it is frequently
difficult to be sure that the activation or inhibition of their
activity is a direct effect. Well known (direct or indirect)
targets of PKA phosphorylation are 1) enzymes involved in trehalose
synthesis and degradation, including trehalase and
trehalose-6-phosphate synthase; 2) those involved in glycogen synthesis
and degradation, such as glycogen synthase and glycogen phosphorylase;
and 3) those enzymes involved in the glycolytic flux, such as
phosphofructokinase and fructose-bisphosphatase (3, 7). A less known
target is pyruvate kinase, whose in vitro phosphorylation by
PKA has recently been reported (8, 9). The level of expression of PFK26 and PFK27 genes, coding for
6-phosphofructo-2-kinase, depend on the carbon source, via a cAMP
pathway (10). In the presence of fermentable sugars yeast glycolysis is
fully activated; the initiation of the glycolytic flux seems to rely on
the coordinated triggering of multiple events, including allosteric
regulation of enzymatic activities, protein modification, and
modulation of gene expression.
The main objective of our group is to study the mechanism of in
vivo activation of PKA by cAMP and the participation of the substrate in this process using lower eukaryotic models
(11-14). While looking for PKA substrates in S. cerevisiae, we found that both isoforms of pyruvate kinase, Pyk1
and Pyk2, are substrates of PKA. Pyk 1 is the last enzyme in the
glycolytic pathway of sugar catabolism; it catalyzes the irreversible
conversion of phosphoenolpyruvate (PEP) to pyruvate by the addition of
a proton and the loss of a phosphate group, which is transferred to
ADP. The enzyme is allosterically activated by fructose
1,6-bisphosphate (FBP), and its gene expression is
dependent on the presence of glucose in the culture medium
(15). Mck1, a member of the glycogen synthase kinase 3 family, has been
reported to be a negative regulator of Pyk1 (16) through the negative
regulation of its phosphorylation by PKA (9). With the completion of
the yeast genome sequencing project, an open reading frame coding for a
protein with high homology to Pyk1 has been reported. The
characterization of this gene indicated the existence of a Pyk2
protein, which is insensitive to FBP and whose expression is repressed
by glucose (17). In this work we identify both Pyk1 and Pyk2 as
in vitro and in vivo substrates of PKA,
characterize their behavior as PKA substrates, and present a
preliminary study of the effect of phosphorylation on the kinetics of
pyruvate kinase.
 |
EXPERIMENTAL PROCEDURES |
Materials--
All chemicals were reagent grade. Yeast growth
medium supplies were from Difco Laboratories and Merck. HA-probe
antibody (F-7), protein A/G Plus-agarose, anti-GST antibody GST(Z-5),
and anti-goat IgG-peroxidase-conjugated, Chemiluminescence
Luminol reagent were from Santa Cruz Biotechnology, Inc.
[ -32P]ATP and [32P]orthophosphate were
from PerkinElmer Life Sciences. Phosphocellulose paper (P81) was from
Whatman. Colloidal Coomassie Blue stain was from Novex. Protein kinase
catalytic subunit from bovine heart, protein kinase inhibitor amide
fragment 6-22, IgG-peroxidase conjugated, PEP, NADH, ATP, ADP, FBP,
lactate dehydrogenase, and phosphatase alkaline-biotinamidocaproyl
(P1318) and streptavidin immobilized on iron oxide (S2415) were from
Sigma Chemical Co. Polyclonal anti-pyruvate kinase (rabbit
muscle) was from Rockland. Nitrocellulose membrane was from MSI.
Trypsin, of modified sequencing grade, was from Promega, Madison, WI.
Yeast Strains and Plasmids--
The strains, genotype, and
genetic nomenclature used in this study are listed in Table
I. The plasmid Yep51-BCY1
expresses the BCY1 gene under the control of the
GAL10 promoter (13). The plasmid Ycp50-HATPK1
codes for a HA-Tpk1 fusion protein under the control of the
TPK1 promoter (generously provided by Stephen Garrett,
Department of Microbiology and Molecular Genetics, New Jersey Medical
School). Strains EJ758-YOR347C and EJ758-YAL038W expressing the
respective open reading frames fused to glutathione S-transferase (GST) from pYEX4T1 plasmid under control of
the CUP1 promoter were purchased from Research Genetics,
Inc. The plasmids contained in the EJ758-YOR347C and EJ758-YAL038W
strains were recovered for further experiments using a plasmid
preparation protocol described for yeast cells (20). The
sequence of each ORF was confirmed using the primer F,
5'-GAATTCCAGCTGACCAC-3', and primer R, 5'-GATCCCCGGGAATTGCCAT-3'.
The vector pEG(KG) contains the GST gene cloned downstream of the
galactose-inducible CYC1 promoter (21). Yeast strains were
transformed by the lithium acetate method (22).
Growth Media--
Yeast media were prepared as described
previously (23). Strains were grown on rich medium containing 2%
Bactopeptone, 1% yeast extract, and 2% galactose (YPgal) or 2%
glucose (YPG). Synthetic media containing 0.67% yeast nitrogen base
without amino acids and 2% glucose plus the necessary additions to
fulfill auxotrophic requirements were used to maintain the selectable
plasmids (SD). Solid media contained 2% agar.
Standard PKA Assay--
C subunit activity was determined by
assay of phosphotransferase activity with Leu-Arg-Arg-Ala-Ser-Leu-Gly
(Kemptide) as substrate. The assay was started by mixing the different
amounts of PKA coming from different sources (protein kinase catalytic
subunit from bovine heart (Cb), semi-purified HA-Tpk1,
HA-Tpk1·Bcy1 complex, or crude extract) with assay mixture to give 50 mM potassium phosphate, pH 7.5, 0.1 mM EGTA,
0.1 mM EDTA, 15 mM MgCl2, 10 mM 2-mercaptoethanol (buffer PA), 0.1 mM
[ -32P] ATP (700 dpm/pmol) plus 200 µM
Kemptide and 10 µM cAMP, when added. After 15 min at
30 °C, aliquots were processed according to the phosphocellulose
paper method (24). PKA assays were linear with time and protein
concentration. PKA activity is expressed in units: one unit is defined
as the amount of enzyme catalyzing the incorporation of 1 pmol of
phosphate to protein substrate per minute at pH 7.4 at 30 °C.
Cb was reconstituted in 50 mM dithiothreitol and the units used in the assays (expressed as picomoles of phosphate incorporated to a synthetic substrate per minute) were estimated according to the instructions of the manufacturer, except when indicated, where the activity was assayed under our standard assay conditions.
Immunoprecipitation--
Strain
1115+HA-TPK1+YEp51-BCY1 was grown in
YPgal medium during 16 h at 30 °C. Cells were lysed by
disruption with glass beads at 4 °C in 0.1 M potassium
phosphate, pH 7; 1 mM EDTA, 0.1 mM EGTA, 5%
glycerol, 0.1 mM phenylmethanesulfonyl fluoride, 2 µg/ml leupeptin, 3 µg/ml antipain, and 0.5% Triton X-100 (buffer
A). Cell debris was pelleted by centrifugation at 5000 × g for 5 min, and the crude extract was used to
immunoprecipitate HA-Tpk1·Bcy1 complex. A 0.5-ml aliquot of crude
extract (2.5 mg/ml) was incubated with anti-HA (4 mg/ml) antibody or
nonspecific antibody during 1 h at 4 °C, followed by addition
of A/G agarose (30 µl), and incubation for 16 h at 4 °C. The
immunoprecipitates were washed with 5 ml of buffer A plus 0.1 M NaCl. Phosphorylation of immunoprecipitates was performed
by incubation with 0.1 mM [ -32P]ATP (700 dpm/pmol) in buffer PA, plus 10 µM cAMP, when added. The
immunoprecipitates were subjected to SDS-PAGE. The gel was stained with
colloidal Coomassie Blue, destained, and autoradiographed. Protein
kinase activity of aliquots of each immunoprecipitate was assayed under
the standard assay conditions.
Peptide Mass Mapping by MALDI--
The selected protein
bands were excised, washed, reduced, and S-alkylated
essentially as described (25). A sufficient volume of 2 ng/µl trypsin
in 5 mM NH4HCO3 was added to cover
the gel pieces, and digestion was performed overnight at 32 °C in an
incubator. The digests were then acidified by the addition of a 1/10
vol. of 2% trifluoroacetic acid prior to MALDI analysis. A Reflex III matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany), equipped with a 337-nm nitrogen laser and a Scout-384 probe, was used to obtain
positive ion mass spectra of digested protein with pulsed ion
extraction in reflectron mode. An accelerating voltage of 26 kV
was used with detector bias gating set to 2 kV and a mass cut-off of
m/z 650. Thin-layer matrix surfaces of
-cyano-4-hydroxycinnamic acid mixed with nitrocellulose were
prepared as described previously (26). An aliquot (0.4 µl) of
acidified digestion supernatant was deposited onto the thin layer and
allowed to dry prior to desalting with water. Mass spectra were clean
and interpretable. Peptide mass fingerprints thus obtained were
searched against the non-redundant protein data base placed in the
public domain by NCBI, using the program MASCOT (27).
Induction of GST-ORF and Purification of Fusion
Proteins--
Cell patches of EJ758-YOR347C and EJ758-YAL038W were
inoculated in SD-Ura liquid medium, grown overnight, and re-inoculated into SD-Ura-Leu, grown to A600 = 0.8, and
induced with 0.5 mM Cu2SO4 for
2 h before harvest. Cells were homogenized with glass beads in 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 4 mM MgCl2, 5 mM dithiothreitol, 10%
glycerol, and 0.5 M NaCl plus 2 µg/ml leupeptin, 1 mM phenylmethanesulfonyl fluoride, 1 mM
benzamidine, and 3 µg/ml antipain (buffer B). The GST protein was
purified from crude extract of 1115+GST cultures induced by adding galactose to a final concentration of 2% (21). GST
protein and GST-Pyk1 and GST-Pyk2 fusion proteins were purified by
glutathione agarose chromatography in buffer B plus 1 M
NaCl. Proteins were eluted by 1 h incubation at 37 °C with
buffer B, 1 M NaCl, 40 mM glutathione, 20 mM dithiothreitol. After dialysis in buffer, 20 mM Tris-HCl, pH 7.4, 2 mM EDTA, 4 mM MgCl2, 1 mM dithiothreitol, 55 mM NaCl, 50% glycerol, the preparations were stored in
aliquots at 20 °C. The efficiency of elution of either GST-Pyk1
and GST-Pyk2 was low; therefore, for the experiments of Figs. 4 and 5,
where a high concentration of the proteins was needed, the GST fusion
proteins were used bound to the glutathione-agarose. The protein
concentration of the immobilized enzyme was estimated by Coomassie Blue
staining of the proteins eluted with loading buffer and run on
SDS-PAGE.
In Vitro Phosphorylation of Pyk1-GST and
Pyk2-GST--
Semi-purification of HA-Tpk1 was performed by
immunoprecipitation from crude extract of
1115+HA-TPK1 strain grown for 16 h at
30 °C in SD-Ura. The immunoprecipitation was performed using anti-HA
(4 mg/ml) or nonspecific antibody (rabbit preimmune serum) as described
above. The immunoprecipitates were washed first with buffer A plus 1 M NaCl, followed by a wash with buffer A. Protein kinase
activity of the immunoprecipitated HA-Tpk1 was determined under the
standard assay conditions. This HA-Tpk1 preparation displayed a /+
cAMP activity ratio of 0.9 and a Km value of 50 µM for Kemptide (data not shown; comparable to value
reported in Ref. 28). The in vitro phosphorylation
assays were performed in a final volume of 40 µl using partially
purified HA-Tpk1 (as described above) or Cb (of commercial
origin) as PKA source. The assay was started by mixing the substrates
GST-Pyk1 and GST-Pyk2 (amount indicated in each case) with 0.1 mM [ -32P]ATP (1000-1300 dpm/pmol) in
buffer PA and 15 µg/ml protein kinase inhibitor amide fragment 6-22, when added. The reactions were incubated 15 min at 30 °C. The
incorporation of phosphate into GST-Pyk1 and GST-Pyk2 was determined by
scintillation counting of phosphorylated enzyme excised from dried
SDS-PAGE gels. Alternatively, SDS-PAGE-dried gels were exposed to
autoradiography or subjected to digital imaging analysis (Bio-Imaging
Analyzer Bas-1800II and Image Gauge 3.12, Fujifilm).
In the experiment in Fig. 4, yeast crude extracts derived from strains
1115 and tpk1w1, grown on YPG medium
during 16 h at 30 °C, were used as the source of PKA activity.
The crude extracts were prepared as described above. Samples of crude
extract (100 µg/ml) were mixed with semi-purified GST-Pyk1 or
GST-Pyk2 (10-20 µg) in buffer PA plus 0.1 mM
[ -32P]ATP (2200 dpm/pmol) and 10 µM
cAMP, when added, in a final volume of 40 µl. After 30 min at
30 °C, aliquots were subjected to SDS-PAGE and autoradiography. The
total amount of catalytic activity in the crude extract preparations
was determined under the standard PKA assay conditions.
Immunological Analysis--
Samples of crude extract or
purified preparations of GST-Pyk1, GST-Pyk2, and GST were analyzed by
SDS-PAGE, blotted onto nitrocellulose membranes using 25 mM
Tris, 192 mM glycine, 20% (v/v) methanol buffer in a
Transphor apparatus. Blots were blocked with 5% nonfat milk, 0.05%
Tween 20 in Tris-buffered saline. Primary antibodies were used at a
dilution of 1/500 for anti-GST antibody and 1/1000 for anti-pyruvate
kinase antibody. Secondary antibodies were used at 1/10,000
(anti-rabbit and anti-goat IgG-peroxidase-conjugated). After three
washes the blots were developed with Chemiluminescence Luminol reagent,
and immunoreactive bands were visualized by autoradiography and
analyzed by digital imaging.
In Vivo Phosphorylation of GST-Pyk1 and GST-Pyk2--
Yeast
strains EJ758+GST-PYK2, EJ758+GST-PYK1,
tpk1w1+GST-PYK2, and
tpk1w1+GST-PYK1 were grown in SD-Ura
medium during 16 h at 30 °C. The cultures (20 ml) were
centrifuged, and the cell pellets were washed with phosphate-free YPD
medium, resuspended in the same medium (30 ml), grown until exponential
phase (A600 = 0.8), concentrated to 3 ml, and
further incubated with 0.5 mCi of [32P]orthophosphate.
After 2 h the induction of GST fusion protein was performed as
described above. The cells were washed with cold saline buffer
and disrupted with glass beads in 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 4 mM MgCl2, 5 mM dithiothreitol, 10% glycerol, 0.5 M NaCl
plus 2 µg/ml leupeptin, 1 mM phenylmethanesulfonyl fluoride, 1 mM benzamidine, 3 µg/ml antipain, 10 mM NaF, 5 mM -glycerophosphate, and 1 mM NaVO4. 32P uptake was measured
and was similar for both wild type and tpk1w1
strains. GST-Pyk1 and GST-Pyk2 were purified by glutathione-agarose chromatography and subjected to SDS-PAGE. The gel was dried and analyzed by digital imaging.
Determination of Pyruvate Kinase Activity--
The pyruvate
kinase activity was determined in 50 mM imidazole buffer,
pH 7.0, containing 62 mM MgCl2 and 100 mM KCl. Under standard conditions, 1.5 mM ADP,
1.5 mM FBP as activator, and different amounts of PEP were
used. The reaction was coupled to NADH oxidation by addition of 1 unit
of lactate dehydrogenase per milliliter and 0.22 mM NADH.
The time course of the reaction was monitored at 30 °C by measuring
the decrease in absorbance at 340 nm. For the determination of
kinetic parameters, the pyruvate kinase preparation used came from a
partial purification by precipitation from crude extracts with 60%
(NH4)2SO4. Pellets were stored at 20 °C and desalted through Sephadex G-25 in imidazole buffer, immediately before the assay. Pyruvate kinase activity is expressed in
enzyme units: 1 enzyme unit causes the transphosphorylation of 1 µmol of phosphate from PEP to ADP per minute at 37 °C, under standard assay conditions.
Alkaline Phosphatase Treatment of Pyk1--
Alkaline phosphatase
was used to dephosphorylate the endogenous pyruvate kinase (Pyk1)
present in crude extracts of strain 1451. The
dephosphorylation reactions were performed for 30 min at 37 °C in a
total volume of 80 µl. 300 µg of crude Pyk1 preparations, obtained
through precipitation with 60%
(NH4)2SO4 and desalting, as
described above, were incubated with 0.1 M Tris-HCl, pH
9.5, 50 mM MgCl2, 0.1 M NaCl, and
100 units of phosphatase alkaline-biotinamidocaproyl. The reaction was
terminated by the addition of 150 µl of streptavidin immobilized on
iron oxide. The alkaline phosphatase biotinamidocaproyl-streptavidine iron oxide complex was incubated for 30 min at room temperature and
then magnetically separated for 15 min. The supernatant was used as a
source of dephosphorylated enzyme for the measurement of Pyk1 activity.
Protein Determination and Analysis of Kinetic Data--
Protein
was determined by the Bradford assay (29) with bovine serum albumin as
standard. Kinetic data of Pyk phosphorylation by PKA were analyzed
according to the Michaelis-Menten equation. The substrate (Pyk)
concentration used in the assays of Fig. 5 was found to be very low.
Under these conditions the combination of the substrate with the enzyme
becomes rate-limiting, and the Michaelis-Menten equation becomes
v = Vmax/Km
[S], where S is the substrate concentration. The tangent of the curve
at the origin gives the specificity constant value
Vmax/Km, which is the more
critical parameter in determining the specificity of an enzyme for a substrate.
Kinetic analysis of pyruvate kinase activity was performed using Hill
equation (Fig. 7). The kcat presented in Fig.
7B was calculated normalizing the
kcat expressed in units per milligram of total
protein in the preparation (units/milligram of protein) to the Pyk
relative abundance. This parameter was estimated as a ratio between the
immunoreactive band of Pyk in the Western blots relative to total
Coomassie Blue-stained protein, quantified by bio-imaging analysis.
Reproducibility of Results--
All experiments were repeated at
least twice with independent transformants, cultures, and enzymatic
preparations. The results always showed consistent trends,
i.e. different transformants and extracts gave highly
reproducible results. In all cases, results from representative
experiments are shown.
 |
RESULTS |
Identification of Substrates of Yeast PKA--
To identify
possible targets of S. cerevisiae PKA our initial approach
was to immunoprecipitate PKA holoenzyme and to further analyze the
co-immunoprecipitated proteins. The rationale was to overexpress a
tagged Tpk1 protein together with an excess of the regulatory subunit
Bcy1 to form a tagged holoenzyme containing Tpk1. Extracts from a
strain cotransformed with Ycp50-HATPK1 and Yep51-BCY1 were subjected to immunoprecipitation with
anti-HA antibody as described under "Experimental Procedures."
Controls of immunoprecipitation were done using nonspecific antibody.
The immunoprecipitates were washed with 0.2 M NaCl and
assayed for PKA activity measuring the ratio of activity /+ cAMP. For
anti-HA immunoprecipitates, the ratio was 0.2, indicating a good
holoenzyme preparation; no PKA activity was detected in nonspecific
immunoprecipitates. The immunoprecipitates were subjected to
phosphorylation by incubation with [ -32P]ATP in the
absence or presence of cAMP, finally resolved by SDS-PAGE, and
autoradiography. We looked for those proteins that had a
phosphorylation pattern dependent on the specific anti-HA antibody and
with a high relative radioactivity to protein ratio. The results in
Fig. 1 show the Coomassie Blue staining
and phosphorylation pattern of the immunoprecipitated proteins. A
phosphoprotein of 55 kDa was selected as a good candidate, because, in
addition, it showed a moderate increase of its phosphorylation in the
presence of cAMP. The protein band was cut from the gel and submitted
to tryptic digestion and mass spectrometric analysis (MALDI). A MASCOT (27) search of the S. cerevisiae subset of the NCBI
non-redundant data base was performed using the MALDI mass spectrum of
this band. 21/22 peptide masses matched two almost identical pyruvate kinase sequences (GenBankTM accession numbers 4180 and
6319279), with identical MASCOT probability scores of 274. This
analysis revealed that the 55-kDa band was pyruvate kinase 1 (Pyk1).
Because Pyk1 and the recently identified isoform Pyk2 (17) have a high
degree of similarity in their protein sequence (68% identity), we
decided to follow this work with both enzymes, although Pyk2 was not
detected in the immunoprecipitates.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 1.
Co-immunoprecipitation of Pyk1 with yeast PKA
holoenzyme. Crude extract from
1115+HA-TPK1+YEp51-BCY1 cells, overexpressing the
Bcy1 protein and expressing HA-Tpk1 fusion protein, was subjected to
immunoprecipitation (IP) with either anti-HA antibodies
(lanes 1 and 2) or nonspecific antibody
(lanes 3 and 4). The resulting immune complexes
were subjected to phosphorylation (as described under "Experimental
Procedures") without cAMP (lanes 2 and 4) or
with 10 µM of cAMP (lanes 1 and 3).
The samples were separated in SDS-PAGE. The gel was stained with
Coomassie Blue colloidal (upper gel) and autoradiographed
(lower gel). The protein band at 55 kDa showing specific
cAMP-dependent phosphorylation is indicated with an
arrow. The asterisk shows for comparison a band
with specific phosphorylation, high radioactivity/protein ratio, but no
cAMP dependence. The selected protein band was excised and analyzed
with MALDI.
|
|
Phosphorylation of Pyk1 and Pyk2 by PKA in
Vitro--
In vitro phosphorylation of Pyk1 and Pyk2 was
assayed using either Tpk1 or the catalytic subunit from bovine heart
PKA (Cb) as enzyme sources. GST-Pyk1 and GST-Pyk2 were
purified from strains containing plasmids coding for fusion proteins
GST-YAL038W and GST-YOR347C, respectively, under a
copper-dependent promoter. ORF sequences were verified by
DNA sequencing, because the commercially available clones were not
checked. Samples of the purified proteins were analyzed by SDS-PAGE and
Western blotting using either anti-GST or anti-Pyk antibodies (Fig.
2). A band of ~84 kDa, as expected for
the molecular mass of both fusion proteins, was detected both by
Coomassie Blue staining (Fig. 2A) or by Western blot using anti-GST antibody (Fig. 2B). Fig. 2C shows that
an antibody raised against rabbit muscle pyruvate kinase whole molecule
cross-reacted with Pyk1 but did not recognize Pyk2. This result was
unpredictable, because both yeast pyruvate kinases are ~45%
identical to rabbit muscle pyruvate kinases M1 and M2. However, upon
manual comparison of the sequences from the very few regions where
higher eukaryotic pyruvate kinases are different, with the S. cerevisiae Pyk sequences, we could find higher identity for Pyk1
than for Pyk2 with the rabbit Pyks.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 2.
Analysis of GST-Pyk1 and GST-Pyk2
purification. Equal amounts of purified preparations of GST-Pyk1,
GST-Pyk2, and GST proteins were electrophoresed on 10% SDS-PAGE and
stained with Coomassie Brilliant Blue (Panel A,
Coomassie). Gels equivalent to those in A were blotted and
incubated with anti-GST antibody (Panel B, GST immunoblot)
or anti-pyruvate kinase antibody (Panel C, Pyk
immunoblot) as described under "Experimental Procedures."
|
|
Different aliquots of the purified preparations of GST-Pyk1 and
GST-Pyk2 were submitted to phosphorylation conditions, using [ -32P]ATP and either Cb or HA-Tpk1
preparation. The samples were subjected to SDS-PAGE and
autoradiographed. Fig. 3 shows that Pyk1
and Pyk2 were phosphorylated by both bovine and yeast PKA catalytic
subunits, with an increase in phosphorylation accompanying the increase in substrate concentration. Heterologous PKA phosphorylation was completely inhibited by the specific protein kinase peptide inhibitor, as expected. Control phosphorylation reactions were assayed for the
yeast HA-Tpk1 by using immunoprecipitates prepared using nonspecific antibody as source of PKA. Control GST protein was neither
phosphorylated by Cb nor Tpk1 (not shown).

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 3.
In vitro phosphorylation of
GST-Pyk1 and GST-Pyk2. Different amounts of purified GST-Pyk1
(A and B) or GST-Pyk2 (C and
D) were incubated with 2 units of Cb
(A and C) or with 5 units of HA-Tpk1
(B and D) and [ -32P]ATP, in a
final volume of 40 µl. Radiolabeled products were resolved by
SDS-PAGE, stained with Coomassie Brilliant Blue (lower part of
each panel) and examined by autoradiography (upper part of
each panel). Bands corresponding to GST-Pyk1 and GST-Pyk2 are
indicated by arrows. PKI (6-22), protein kinase
inhibitor amide fragment; N.S., control assay performed with
the immunoprecipitate obtained with nonspecific preimmune serum instead
of anti-HA antibody.
|
|
To corroborate by a different approach the phosphorylation of Pyk1 and
Pyk2 by yeast PKA, we assayed the phosphorylation in vitro
using as a source of PKA crude extracts from a wild type (WT) strain
(1115) containing normal levels of holoenzyme and from a
strain with a deletion of TPK2 and TPK3 genes and
containing and attenuated form of tpk1 (tpk1w1). The
mutant allele tpk1w1 contains a single missense
mutation in the codon for an amino acid very conserved among PKA
catalytic subunits. This mutant PKA catalytic subunit gene encodes a
functionally attenuated protein (19). The WT extract displayed a /+
cAMP activity ratio of 0.2, indicating it was a good source of
holoenzyme; on the contrary we could not measure PKA activity in either
permeabilized cells or crude extracts from the
tpk1w1 strain (data not shown). Equal amounts of
GST-Pyk1 and GST-Pyk2 were submitted to phosphorylation by either of
the two extracts and [ -32P]ATP, and the reactions were
analyzed by SDS-PAGE and autoradiography (Fig.
4A). Both proteins were
phosphorylated by WT extracts and not by tpk1w1
extracts, indicating that the phosphorylation was
PKA-dependent. GST-Pyk2 was more efficiently phosphorylated
by the WT extract than GST-Pyk1, as shown in Fig. 4B. Under
these assay conditions phosphorylation of either GST-Pyk1 or GST-Pyk2
was not dependent on cAMP, even though the WT extracts showed
cAMP-dependent activity when using Kemptide as
substrate.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 4.
In vitro phosphorylation of
GST-Pyk1 and GST-Pyk2 by WT and tpk1w1 crude
extracts. Samples containing 10-20 µg of immobilized GST-Pyk1
(lanes 6-8), GST-Pyk2 (lanes 3-5), or no
protein (lanes 1 and 2) were incubated with crude
extracts from tpk1w1 strain (panel A,
lanes 2, 3, and 6) or crude extract
from 1115 strain in the absence (panel A,
lanes 1, 4, and 7) or in the presence
(panel A, lanes 5 and 8) of 10 µM cAMP as described under "Experimental Procedures"
and subjected to SDS-PAGE and autoradiography. The ratio
phosphorylation/protein (panel B) was determined by
densitometric analysis of Coomassie Blue-stained bands and the
corresponding autoradiography of lanes 5 and 8 of
panel A.
|
|
Preliminary results from Cytryñska et al. (8) and
Rayner et al. (9) showed that Pyk1 could be phosphorylated
in vitro by Tpk2 and Tpk1, respectively. From our last
results and from the results of the immunoprecipitation (Figs. 1 and 3)
we can say that both Pyk1 and Pyk2 are phosphorylated by Tpk1
in vitro.
Kinetic Constants for Pyk1 and Pyk2 Phosphorylation--
To
analyze whether the kinetics of phosphorylation of both Pyk1 and Pyk2
corresponded to those of a PKA substrate, we measured the kinetic
parameters of phosphorylation using Cb as enzyme source. GST-Pyk1 and GST-Pyk2 were used as immobilized proteins, because the
concentration of the eluted proteins was not sufficient to be assayed
at high concentrations. It has been well described that protein
affinity chromatography can be used as a method to estimate binding
constants (18, 30). It has been assumed that the bound ligand (in this
case the GST-Pyk) is always in equilibrium with the solution ligand (in
this case the Cb) and that interactions of solid
phase-bound protein with liquid-phase ligand are the same as
interactions in liquid state. The results for interactions, which have
been measured in the literature by more than one method, agree well
(30).
Fig. 5A shows the dependence
of phosphorylation of GST-Pyk1 and GST-Pyk2 by Cb on enzyme
concentration. At the point of maximum phosphorylation, under these
experimental conditions, Cb catalyzed the incorporation of
0.5 mol of phosphate/mol of GST-Pyk2 and 0.15 mol of phosphate/mol of
GST-Pyk1. To find the kinetic parameters for the phosphorylation of
GST-Pyk1 and GST-Pyk2 by Cb, experiments were carried out
using variable concentrations of the two immobilized protein substrates
in phosphorylation assays using 2 units of Cb subunit (Fig.
5B). The upper panel of Fig. 5B shows
the autoradiography of phosphorylated proteins; quantification of
incorporated phosphate was measured by liquid scintillation counting of
the sliced bands and is shown in the lower panel of Fig.
5B. Experimentally we could not attain the
Vmax due to the limitation in increasing the
substrate concentration. However, some information can be obtained from
the data of Fig. 5B by comparing the velocities of
phosphorylation of Kemptide and Pyk-GST substrates using the 2 units of
Cb during 15 min. The phosphorylation of this synthetic peptide would have reached a total of 30 pmol in the 15-min period, according to the manufacturer's indication; the phosphorylation of
Pyk1-GST and Pyk2-GST reached 9 and 15 pmol, respectively, in the
15-min period. These results indicate that the velocities of
phosphorylation for the three substrates are quite similar. In this
estimation we have not taken into account the Km values for the two Pyk substrates. This parameter can not be
calculated, because the concentrations of protein substrate used turned
out to be very low; however, the parameter
Vmax/Km, which can be
obtained from the tangents to the origin of the curves of Fig.
5B (see "Experimental Procedures") is the most critical parameter in determining the specificity of an enzyme for a substrate. The data of Fig. 5C show the specificity constants for the
two substrates as compared with Kemptide, experimentally measured using
Cb. When comparing both GST-Pyk substrates, it can be seen that GST-Pyk2 is a better substrate for Cb than GST-Pyk1.
The efficiency for in vitro phosphorylation of GST-Pyk1 and
GST-Pyk2 by Cb was 8- and 4-fold lower than for Kemptide
under the same conditions. However, it is known that natural PKA
substrates are not always better than the corresponding peptides
derived from it or peptides used as models, because even in the case of
sharing the same substrate determinants, the phosphorylation site
structure in the protein substrate is likely to be more constrained
(31).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Kinetic behavior of in vitro
phosphorylation of GST-Pyk1 and GST-Pyk2 by catalytic subunit
from bovine heart PKA. Immobilized GST-Pyk1 (5 µM)
and GST-Pyk2 (3 µM) were incubated with the indicated
amounts (units/40 µl) of Cb subunit and 0.1 mM [ -32P]ATP (1000 dpm/pmol) for 15 min at
30 °C (panel A). In panel B, 2 units/40 µl
of Cb and 0.1 mM [ -32P]ATP
(1000 dpm/pmol) were incubated with the indicated concentration of
GST-Pyk1 or GST-Pyk2. After incubation, samples were subjected to
SDS-PAGE and autoradiography. The incorporation of phosphate into the
substrate was determined by scintillation counting of the
phosphorylated enzyme band excised from SDS-PAGE gels. Phosphorylation
of Kemptide was determined by the phosphocellulose paper
method. A portion of the autoradiograms, including the position of
pyruvate kinase, is shown above each panel. Panel
C, the specificity constants
(kcat/Km) expressed as
pmol·(min·unit) 1µM 1, calculated
for GST-Pyk1 and GST-Pyk2 as described under "Experimental
Procedures." The estimated parameters used for Kemptide were
Km = 45 µM and
kcat = 17 pmol/min·unit. Values are expressed
as means ± S.E. from two separate experiments.
|
|
Phosphorylation of Pyk1 and Pyk2 by Endogenous PKA in Vivo--
To
demonstrate the in vivo phosphorylation of Pyk1 and Pyk2,
yeast cells from WT and tpk1w1 strains expressing
GST-Pyk1 and GST-Pyk2 were metabolically labeled with
32Pi; GST-Pyk1 and GST-Pyk2 from those cells
were purified through glutathione-agarose affinity chromatography. The
purified proteins were analyzed by SDS-PAGE and digital imaging
analysis. The results indicate that GST-Pyk1 (Fig.
6A) and GST-Pyk2 (Fig.
6B) were in fact phosphorylated in vivo and that
phosphorylation was PKA-dependent, because there was no
radiolabeled phosphoprotein that comigrated with GST-Pyk1 and GST-Pyk2
in the purification from tpk1w1-radiolabeled
strains.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 6.
In vivo phosphorylation of
GST-Pyk1 and GST-Pyk2 by yeast PKA. Wild type cells
(EJ758) and mutant tpk1w1
tpk2 tpk3 cells (tpk1w1)
expressing GST-Pyk2 (panel A) or GST-Pyk1 (panel
B) were metabolically labeled with 32Pi.
The GST fusion proteins were purified by glutathione-agarose
chromatography and subjected to SDS-PAGE. The gel was stained with
Coomassie Brilliant Blue (lower part of each panel) and
subjected to digital imaging (upper part of each
panel).
|
|
Effect of Phosphorylation on Pyruvate Kinase Activity--
To
analyze whether phosphorylation by PKA had an effect on pyruvate kinase
activity, our rationale was to use a classic genetic approach and
determine the kinetic parameters Vmax and
Km of endogenous, partially purified pyruvate
kinase, derived from strains with different degree of PKA activity. The
aim was to find a correlation between pyruvate kinase activity and PKA
activity. On the top scale with high PKA activity, we used strain
1451, with a mutation in the BCY1 gene
(bcy1-14) consisting of a small deletion in the -helix C
of cAMP binding domain A, which confers to the holoenzyme high
constitutive activity, almost independent of cAMP (11). Following in
the order of PKA activity we used a WT strain (1115), with
the same genetic background as the 1451 strain. Finally the
tpk1w1 strain was used as a source of poor PKA
activity (see above). Using this approach we expected to obtain a
pyruvate kinase with a variable degree of modification by PKA
phosphorylation, the higher modification being expected in the
1451 strain, and the lower in the tpk1w1
strain. In fact the ratio of /+ cAMP PKA activity in extracts from
the cells in logarithmic stage of growth in YPD, measured in
permeabilized cells, reflects a ratio of 0.2 for strain 1115 and 0.9 for strain 1451, whereas tpk1w1
strains display no activity either in the absence or presence of cAMP.
Previous work from our laboratory (11, 13) has shown that strain
1451, when compared with the wild type strain
1115, shows a higher severity in classic
PKA-dependent phenotypes such as glycogen accumulation,
respiratory capacity, and growth at 37 °C.
It has been reported that the expression of Pyk1 mRNA is dependent
on the presence of glucose in the growth medium, with a decrease in
expression along the diauxic shift (32, 33). Previous to the
study of the relationship between phosphorylation and Pyk activity, we
decided to investigate the level of expression of Pyk in two different
stages of growth in YPD medium: before and after diauxic shift (data
not shown). We determined the specific activity (units per milligram of
total protein) of Pyk in both stages by measuring the catalytic
activity in the absence and in the presence of FBP and the levels of
Pyk by Western blot using anti-Pyk antibody. The diauxic shift was
followed by the change in A600 and by
measurement of glucose consumption. As expected, according to the
reports on the Pyk mRNA levels and glucose concentration (32, 33),
the specific activity of Pyk was glucose-dependent and
decreased during the post-diauxic shift; this phenomenon was observed
for the three strains: 1451, 1115, and
tpk1w1. The decrease in specific activity correlated
with the levels of Pyk1 followed by Western blot. According to these
results the kinetic experiments that follow were performed on partially
purified preparations of Pyk from cells in a pre-diauxic shift stage,
in which the specific activity of Pyk1 is maximal and there is no expression of Pyk2 (17).
We analyzed the kinetic behavior of semi-purified Pyk from each strain
toward PEP in the presence or absence of FBP (Fig. 7A); kinetic parameters
derived from the Hill plot of the curves shown in Fig.
7A are shown in Fig. 7B. In the presence of the allosteric activator FBP (Fig. 7A, right panel),
the K0.5 value for PEP and the
kcat value for the reaction in the three strains were quite similar; the nH value for Pyk1 from
strain tpk1w1 was a little higher, indicating that a
complete shift toward a Michaelis-Menten behavior had not been attained
at 1.5 mM FBP. The K0.5 for PEP and
nH values for the Pyk1 activity measured in the
absence of the allosteric activator, FBP, differed among the three
strains. The most remarkable result is the increase in cooperativity
displayed by the Pyk1 derived from the 1451 strain, with an
increase in the nH and a decrease in the
K0.5 for PEP (Fig. 7A, left
panel, and Fig. 7B). Taken as a whole, the parameters of the enzyme derived from the 1451 strain, which presumably
is more phosphorylated, reflect a more active pyruvate kinase. No significant changes in the kinetic parameters measured in the absence
of FBP have been observed between Pyk preparations derived from strains
1115 and tpk1w1. This lack of difference
is not surprising, because one would expect that phosphorylation events
in a wild type strain would be only transient, and the degree of
phosphorylated molecules would be very low when taking samples from
logarithmically growing cells, as compared with extracts from the
1451 strain, where PKA is constitutively activated and the
degree of phosphorylation of its target substrates might be more
sustained.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 7.
Activity of partially purified pyruvate
kinase from different PKA background strains. Pyk activities were
measured as a function of the concentration of PEP in the absence
(Panel A, left) or in the presence (Panel
A, right) of 1.5 mM FBP in partially
purified samples from tpk1w1, 1115 and
1451 strains, as described under "Experimental
Procedures." The figure shows the data from representative
experiments. Panel B shows the pyruvate kinase activities
and kinetic parameters derived from the experiments in Panel
A. a, kinetic constants determined in the presence of
1.5 mM FBP. b, expressed in units/relative
amount of Pyk as described under "Experimental Procedures."
|
|
To confirm whether the kinetic parameters for the Pyk1 derived from the
1451 strain, suggesting a more active pyruvate kinase in
this strain with higher PKA activity, were due to enzyme
phosphorylation, we examined the effect of protein kinase A and
alkaline phosphatase on Pyk1 activity. Pyk1 preparations from
1451 strain were incubated either with Cb or
with alkaline phosphatase. The phosphatase used could be removed from
the reaction with magnetic beads to avoid interference in the ulterior
pyruvate kinase assay. Pyk1 activity was measured in the more highly
phosphorylated or in the dephosphorylated enzymatic preparation using a
concentration of PEP of 8 mM, the concentration at which
the differences of Pyk1 activity were maximum among the different
phosphorylation sates of the Pyk1 (see Fig. 7). The results, shown in
Fig. 8, indicate that the alkaline
phosphatase treatment resulted in a decrease in Pyk activity of around
35%, as compared with a control in which the preparation was
maintained in the presence of phosphatase inhibitors throughout. This
result indicated that Pyk1 from strain 1451 was
phosphorylated and that the phosphatase treatment produced the loss of
phosphates with the concomitant loss of activity as in the case of Pyk1
from strain tpkw1. The opposite treatment, the
phosphorylation of Pyk1 with Cb, resulted in a stimulatory
effect on Pyk1 activity with an increase of 1.6-fold on the
activity at 8 mM PEP in the absence of FBP (Fig. 8) as
compared with the control. This result indicates that Pyk1 preparations
of 1451 strain were not fully phosphorylated. As a whole, if
we estimate the change in activity from the less phosphorylated to the
more phosphorylated Pyk1, we have an overall change of activity of
almost 2.5-fold produced by PKA.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of phosphorylation and
dephosphorylation on Pyk1 activity. Pyk activity was measured at 8 mM PEP in partially purified samples from 1451 strains phosphorylated with Cb or dephosphorylated with
alkaline phosphatase as described under "Experimental Procedures."
Data are expressed as the percentage of activity of Pyk
(units/milligram of total protein) taking as 100% the activity of an
aliquot incubated in the absence of additional protein kinase or
alkaline phosphatase and in the presence of phosphatase inhibitors.
Results represent mean values ± S.E. with n = 3 for each condition.
|
|
 |
DISCUSSION |
In the present study, we identify and characterize two substrates
of PKA from S. cerevisiae: Pyk1 and Pyk2. We have
demonstrated both in vivo and in vitro
phosphorylation of these substrates. In this work, in vitro
phosphorylation of Pyk1 and Pyk2 was demonstrated using either Tpk1 or
Cb as enzyme source, and the results show that both Pyks
were substrates of both types of PKA. It has been reported that yeast
and mammalian PKAs recognize similar specific features of peptide
substrates (28). Analyzing Pyk1 and Pyk2 sequences for putative PKA
phosphorylation sites, only one canonical RRXS
consensus sequence for PKA was found, corresponding to RRTS in position
19-22 for Pyk1 and 21-24 for Pyk2, conveniently located in the
interface of catalytic domain A and regulatory domain C of the protein,
according to its crystal structure (15). These sequences are conserved
in all the pyruvate kinases from fungal origin sequenced at present,
such as the ones from Schizosaccharomyces pombe,
Aspergillus niger, Emericella nidulans, and
Yarrowia lipolytica, but not in pyruvate kinase isoforms
from higher eukaryotes. Other putative sites for PKA phosphorylation
are far from the ideal consensus sequence, although they cannot be
discarded and they are present either in the catalytic or regulatory
domain of Pyk1. The stoichiometries of phosphorylation attained with
Cb in vitro are compatible with one
phosphorylation site per molecule of pyruvate kinase; however,
optimization of the phosphorylation conditions, so as to compensate for
the low efficiency usually displayed by PKAs, was not assayed. It has
been reported that Pyk1 could be visualized by isoelectric focusing as
four different forms with different isoelectric points, suggesting
multiple phosphorylation sites per monomer, either under in
vitro phosphorylation conditions (8) or analyzing the protein
profile from exponentially growing cells (35). In higher eukaryotes at
least, several kinases have been reported to be responsible for the
multiphosphorylation of pyruvate kinase (36).
The phosphorylation of Pyk1 and Pyk2 by yeast PKA was also assayed
in vitro using crude extracts from strains WT and
tpkw1 as source of protein kinase. A clear
dependence on PKA activity was evident, because extracts from the PKA
weak strain (tpkw1) phosphorylated neither GST-Pyk1
nor GST-Pyk2. However, even though the WT extracts showed
cAMP-dependent phosphorylation of Kemptide, the
phosphorylation of the Pyk recombinant proteins was cAMP-independent.
This lack of dependence on cAMP could be explained if PKA from S. cerevisiae behaves as PKA from the fungus Mucor rouxii,
where we have demonstrated (12) that the protein substrate is involved
in the activation of PKA by cAMP and that, depending on the incubation
conditions, different degrees of activation by cAMP are obtained using
different substrates. In fact, under the phosphorylation conditions
used for Fig. 1, where the source of holoenzyme is an immunoprecipitate
of tagged Tpk1 bound to Bcy1, dependence on cAMP for the
phosphorylation of endogenous Pyk1 was demonstrated.
The kinetic parameters for the phosphorylation reaction were defined
assaying the phosphorylation of GST-Pyk1 and GST-Pyk2 by
Cb. The specificity constant for both protein substrates,
as a measure for the efficiency in phosphorylation, indicates that they
both fall in the range of the specificity constant attained for
Kemptide in a parallel experiment, suggesting that both Pyks are
genuine substrates for Cb. Although we did not measure the kinetic parameters for phosphorylation by yeast PKA, comparative studies between yeast and mammalian PKAs (28) indicate that the yeast
PKA is around 20- to 30-fold less efficient than the mammalian enzymes,
due almost exclusively to a decrease in substrate binding for the yeast
enzyme with a consequent increase in the Km value.
The specificity constant of Cb for GST-Pyk2 is greater than
for GST-Pyk1 (0.1 versus 0.05) (Fig. 5C). A
similar substrate preference is shown for yeast PKA, because the
experiments of Fig. 4B show a higher phosphorylation/protein
ratio for GST-Pyk2 protein. A physiological relevance for Pyk
phosphorylation can be expected, because we could demonstrate in
vivo phosphorylation of the recombinant GST-Pyks (Fig. 6),
absolutely dependent on the presence of active PKA in the cell. We
could not measure the affinity of either Pyk for Cb or for
yeast PKA to attempt a comparison with the intracellular concentration
of Pyk, which in principle could be estimated from data obtained from
the literature. However, it has been reviewed (32) that it is difficult
to draw physiological relevance of protein phosphorylation from the
comparison of Km values with endogenous
concentration, because, from the heterogeneity of substrate sequences
that are known and from the detailed knowledge of the binding of the
protein kinase inhibitor to the multi-substrate protein kinase A
catalytic site, it seems that natural substrates have not evolved to be
"optimum substrates" according to the in vitro
definition. It has therefore been highlighted that not only kinetic
parameters define "physiological" optimum. In fact, it would be
difficult to estimate an endogenous concentration for Pyk1 in yeast,
because it has been described to have a granular cytoplasmic
distribution (37).
Some preliminary experiments were preformed to find a correlation
between phosphorylation and Pyk activity. With this aim we determined
pyruvate kinase activity from partially purified preparations derived
from strains with different levels of PKA activity. If one compares the
behavior of the Pyk derived from the strain in which greater
phosphorylation might be expected (1451) with the one with
lower PKA-mediated phosphorylation (tpk1w1) the
following differences can be found: a discrete shift of the titration
curve for PEP to the left (Fig. 7A) together with an
increase in the cooperativity for PEP in the absence of FBP, for the
Pyk derived from strain 1451, and a Hill coefficient of 1.4 in the presence of FBP, as compared with an nH
of 2 for the less phosphorylated enzyme.
As demonstrated by the results of phosphorylation by Cb and
dephosphorylation by alkaline phosphatase of the Pyk1 derived from the
1451 extracts (Fig. 8), it is apparent that the species obtained from this strain, already partially phosphorylated, when compared with a strain with low PKA activity, can be further
phosphorylated by additional Cb, with a further increase in
enzymatic activity and dephosphorylated by phosphatase with a decrease
in the activity of 2.5-fold as compared with the highly phosphorylated
preparation. These preliminary results suggest that phosphorylation of
Pyk1 by PKA is a positive regulator of enzyme activity, leading to a
bias in the allosteric equilibrium toward the R-state, reflected in the
shift of the saturation curve for PEP and an increase in cooperativity.
This shift in the equilibrium between R and T states could have as a
consequence an increase in the affinity for the activator ligand FBP,
as predicted by the concerted model of allosterism. Although affinity
for FBP has not been measured, a suggestion of increase in affinity can
be speculated from the nH of 2 displayed by the
less phosphorylated Pyk1 in the presence of 1.5 mM FBP as
compared with 1.4 for the more phosphorylated enzyme. A similar modification of the kinetic parameters has been described for a point
mutation in the Escherichia coli pyruvate kinase (38) precisely in a residue (Arg-271) located in the interface between the
catalytic domain A and the regulatory domain C of FBP binding, suggesting that Ser-22 in Pyk1, located structurally in the same interface, might be the target for PKA phosphorylation. It is interesting to mention that yeast cells, containing a point mutation in
a residue (R19Q) located in the vicinity of Ser-22 (Arg-19, contained in the consensus PKA phosphorylation sequence RRTS) from
yeast Pyk1, do not grow in glucose as carbon source (39), indicating
null or low catalytic activity for the Pyk1 from this mutant. The
modification in the kinetic parameters observed, taken as a whole,
suggest that the phosphorylated enzyme is more active; phosphorylation
of rat liver pyruvate kinase by PKA, on the contrary, shifts the
equilibrium between the active and inactive forms of the enzyme to
favor the inactive form (40). An activation of Pyk by PKA could have
been predicted from genetic results (16), which indicate that the
phenotypes of cells overexpressing Pyk1 are similar to the classic
phenotypes observed upon activation of the cAMP/PKA pathway in yeast;
namely, reduction in glycogen accumulation, reduction of sporulation
proficiency, and impairment in growth at 37 °C and in
non-fermentable carbon sources. Very recent results from the same group
(9) also suggest that PKA positively regulates yeast pyruvate kinase
in vivo.
Pyruvate kinase catalyzes the final step in glycolysis, producing
the second of two ATP molecules generated in the glycolytic pathway.
The enzyme converts phosphoenolpyruvate (PEP) and ADP to pyruvate and
ATP. This reaction is a committed step leading to either anaerobic
fermentation or oxidative phosphorylation of pyruvate. In most cells
the reaction is essentially irreversible and is one of the major
control points of glycolysis. The regulation of Pyk is important for
controlling the levels of ATP, GTP, and glycolytic intermediates in the
cell. Allosteric regulation of enzyme activity is a mechanism for
finely tuning biochemical reaction pathways to maintain an appropriate
balance of intracellular substrate and product concentrations; it also
allows an enzyme coordinate its activity with other cellular reactions
and signaling pathways.
The rate of yeast glycolysis was generally assumed to be
determined by the rate of the first irreversible step of the pathway, which is catalyzed by phosphofructokinase. The phosphofructokinase activity increases as a result of rising concentration of its substrate, fructose 6-phosphate, and its main allosteric activator, fructose 2,6-bisphosphate, which in turn is positively regulated at the
transcriptional and post-translational levels by PKA. Activation of
phosphofructokinase increases the concentration of fructose 1,6-bisphosphate, which is an allosteric activator of pyruvate kinase,
the second specific glycolytic enzyme. In this way the glycolysis is
activated progressively by greater concentrations of enzyme substrates
and allosteric activators (34). The results of this work suggest a
second point of regulation by PKA in the glycolysis through the
activation of Pyk by phosphorylation and its consequent increase in
sensitivity to small changes in the levels of its substrate PEP or its
activator FBP that occur, for example, during the shift from
non-fermentable to fermentable carbon sources.
 |
FOOTNOTES |
*
This research was supported in part by grants from the
University of Buenos Aires and Ministerio de Salud through the
Carrillo-Oñativia Fellowship.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel./Fax:
54-11-4576-3342; E-mail: srossi@qb.fcen.uba.ar.
Published, JBC Papers in Press, June 12, 2002, DOI 10.1074/jbc.M201094200
 |
ABBREVIATIONS |
The abbreviations used are:
PKA, protein kinase
A;
Cb, protein kinase A catalytic subunit from bovine
heart;
PEP, phosphoenolpyruvate;
FBP, fructose 1,6-bisphosphate;
HA, hemagglutinin;
GST, glutathione S-transferase;
ORF, open reading frame;
MALDI-TOF, matrix-assisted laser
desorption/ionization time-of-flight;
Pyk1, -2, pyruvate kinases 1 and
2;
WT, wild type.
 |
REFERENCES |
| 1.
|
Toda, T.,
Cameron, S.,
Sass, P.,
Zoller, M.,
and Wigler, M.
(1987)
Cell
50,
227-287[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Toda, T.,
Cameron, S.,
Sass, P.,
Zoller, M.,
Scott, J. D.,
McBullen, B.,
Hurwitz, M.,
Krebs, E. G.,
and Wigler, M.
(1987)
Mol. Cell. Biol.
7,
1371-1377[Abstract/Free Full Text]
|
| 3.
|
Thevelein, J. M.,
and de Winde, J. H.
(1999)
Mol. Microbiol.
33,
904-918[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Rolland, F.,
Winderickx, J.,
and Thevelein, J. M.
(2001)
Trends Biochem. Sci.
26,
310-317[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Entian, K. D.,
and Barnett, J. A.
(1992)
Trends Biochem. Sci.
17,
506-510[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Navas, M. A.,
and Gancedo, J. M.
(1996)
J. Bacteriol.
178,
1809-1812[Abstract/Free Full Text]
|
| 7.
|
Dickinson, J. R.,
and Schweizer, M.
(1999)
in
The Metabolism and Molecular Physiology of Saccharomyces cerevisiae
(Dickinson, J. R.
, and Schweizer, M., eds)
, pp. 209-275, Taylor & Francis Ltd, London
|
| 8.
|
Cytryñska, M.,
Frajnt, M.,
and Jakubowicz, T.
(2001)
FEMS Microb. Lett.
203,
223-227[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Rayner, T. F.,
Gray, J. V.,
and Thorner, J. W.
(2002)
J. Biol. Chem.
277,
16814-16822[Abstract/Free Full Text]
|
| 10.
|
Gonçalves, P. M.,
Griffioen, G.,
Bebelman, J. P.,
and Planta, R. J.
(1997)
Mol. Microbiol.
25,
483-493[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Zaremberg, V.,
and Moreno, S.
(1996)
Eur. J. Biochem.
237,
136-142[Medline]
[Order article via Infotrieve]
|
| 12.
|
Zaremberg, V.,
Donnella-Deana, A.,
and Moreno, S.
(2000)
Arch. Biochem. Biophys.
381,
74-82[Medline]
[Order article via Infotrieve]
|
| 13.
|
Portela, P.,
Zaremberg, V.,
and Moreno, S.
(2001)
Microbiology
147,
1149-1159[Abstract/Free Full Text]
|
| 14.
|
Sorol, M. R.,
Pereyra, E.,
Mizyrycki, C.,
Rossi, S.,
and Moreno, S.
(2001)
Exp. Cell Res.
271,
337-342[Medline]
[Order article via Infotrieve]
|
| 15.
|
Jurica, M. S.,
Mesecar, A.,
Heath, P. J.,
Shi, W.,
Nowak, T.,
and Stoddard, B. L.
(1998)
Structure
6,
195-210[Medline]
[Order article via Infotrieve]
|
| 16.
|
Brazill, D. T.,
Thorner, J.,
and Martin, G. S.
(1997)
J. Bacteriol.
179,
4415-4418[Abstract/Free Full Text]
|
| 17.
|
Boles, E.,
Schulte, F.,
Miosga, T.,
Freidel, K.,
Schlüter, E.,
Zimmermann, F. K.,
Hollenberg, C. P.,
and Heinisch, J. J.
(1997)
J. Bacteriol.
179,
2987-2993[Abstract/Free Full Text]
|
| 18.
|
Martzen, M. R.,
McCraith, S. M.,
Spinelli, S. L.,
Torres, F. M.,
Fields, S.,
Grayhack, E. J.,
and Phizicky, E. M.
(1999)
Science
286,
1153-1155[Abstract/Free Full Text]
|
| 19.
|
Cameron, S.,
Levin, L.,
Zoller, M.,
and Wigler, M.
(1988)
Cell
53,
555-566[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Hoffman, C. S.,
and Winston, F.
(1987)
Gene
57,
267-272[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Mitchell, D. A.,
Marshall, T. K.,
and Deschenes, R. J.
(1993)
Yeast
9,
715-723[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Ito, H.,
Fukuda, Y.,
Murata, K.,
and Kimura, A.
(1983)
J. Bacteriol.
153,
163-168[Abstract/Free Full Text]
|
| 23.
|
Sherman, F.,
Fink, G.,
and Hicks, J. B.
(1981)
Methods in Yeast Genetics: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 24.
|
Roskoski, R., Jr.
(1983)
Methods Enzymol.
99,
3-6[Medline]
[Order article via Infotrieve]
|
| 25.
|
Wilm, M.,
Shevchenko, A.,
Houthaeve, T.,
Breit, S.,
Schweigerer, L.,
Fostsis, T.,
and Mann, M.
(1996)
Nature
379,
466-469[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Shevchenko, A.,
Jensen, O.,
Podtelejnikov, A. V.,
Sagliocco, F.,
Wilm, M.,
Vorm, O.,
Mortensen, P.,
Boucherie, H.,
and Mann, M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
14440-14445[Abstract/Free Full Text]
|
| 27.
|
Perkins, D. N.,
Pappin, D. J. C.,
Creasy, D. M.,
and Cottrell, J. S.
(1999)
Electrophoresis
20,
3551-3567[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Denis, C. L.,
Kemp, B. E.,
and Zoller, M. J.
(1991)
J. Biol. Chem.
266,
17932-17935[Abstract/Free Full Text]
|
| 29.
|
Bradford, M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Formosa, T.,
Barry, J.,
Alberts, B. M.,
and Greenblatt, J.
(1991)
Methods Enzymol.
208,
24-45[Medline]
[Order article via Infotrieve]
|
| 31.
|
Walsh, D. A.,
Glass, D. B.,
and Mitchell, R. D.
(1992)
Curr. Opin. Cell Biol.
4,
241-251[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Moore, P. A.,
Sagliocco, F. A.,
Wood, R. M.,
and Brown, A. J.
(1991)
Mol. Cell. Biol.
11,
5330-5337[Abstract/Free Full Text]
|
| 33.
|
DeRisi, J. L.,
Iyer, V. R.,
and Brown, P. O.
(1997)
Science
278,
680-686[Abstract/Free Full Text]
|
| 34.
|
Gonçalves, P.,
and Planta, R. J.
(1998)
Trends Microbiol.
6,
314-319[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Gygi, S. P.,
Rochon, Y.,
Franza, B. R.,
and Aebersold, R.
(1999)
Mol. Cell. Biol.
19,
1720-1730[Abstract/Free Full Text]
|
| 36.
|
Kumar, A.,
Agarwal, S.,
Heyman, J.,
Matson, S.,
Heitman, M.,
Piccirillo, S.,
Unansky, L.,
Drawid, A.,
Jansen, R.,
Liu, Y.,
Cheung, K.,
Miler, P.,
Gerstein, M.,
Roder, S.,
and Snyder, M.
(2002)
Genes Dev.
16,
707-719[Abstract/Free Full Text]
|
| 37.
|
Pilkis, S. J.,
Claus, T. H.,
and el-Maghrabi, M. R.
(1988)
Adv. Second Messenger Phosphoprotein Res.
22,
175-191[Medline]
[Order article via Infotrieve]
|
| 38.
|
Valentini, G.,
Chiarelli, L.,
Fortin, R.,
Speranza, M. L.,
Galizzi, A.,
and Mattevi, A.
(2000)
J. Biol. Chem.
275,
18145-18152[Abstract/Free Full Text]
|
| 39.
|
Fenton, A. W.,
and Blair, J. B.
(2002)
Arch. Biochem. Biophys.
397,
28-39[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
El-Maghrabi, M. R.,
Claus, T. H.,
McGrane, M. M.,
and Pilkis, S. J.
(1982)
J. Biol. Chem.
257,
233-240[Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. van den Brink, A. B. Canelas, W. M. van Gulik, J. T. Pronk, J. J. Heijnen, J. H. de Winde, and P. Daran-Lapujade
Dynamics of Glycolytic Regulation during Adaptation of Saccharomyces cerevisiae to Fermentative Metabolism
Appl. Envir. Microbiol.,
September 15, 2008;
74(18):
5710 - 5723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lu and T. Jeffries
Shuffling of Promoters for Multiple Genes To Optimize Xylose Fermentation in an Engineered Saccharomyces cerevisiae Strain
Appl. Envir. Microbiol.,
October 1, 2007;
73(19):
6072 - 6077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rossell, C. C. van der Weijden, A. Lindenbergh, A. van Tuijl, C. Francke, B. M. Bakker, and H. V. Westerhoff
Unraveling the complexity of flux regulation: A new method demonstrated for nutrient starvation in Saccharomyces cerevisiae
PNAS,
February 14, 2006;
103(7):
2166 - 2171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Gosmanov, Z. Fan, X. Mi, E. G. Schneider, and D. B. Thomason
ATP-sensitive potassium channels mediate hyperosmotic stimulation of NKCC in slow-twitch muscle
Am J Physiol Cell Physiol,
March 1, 2004;
286(3):
C586 - C595.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Wu, M. Arcand, G. Jansen, M. Zhong, T. Iouk, D. Y. Thomas, S. Meloche, and M. Whiteway
Phosphorylation of the MAPKKK Regulator Ste50p in Saccharomyces cerevisiae: a Casein Kinase I Phosphorylation Site Is Required for Proper Mating Function
Eukaryot. Cell,
October 1, 2003;
2(5):
949 - 961.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|